Author

Ningke Ruan

Institution: Zhengzhou University

Observed institution: Zhengzhou University

OpenAlex ID: A5020184948

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data

2020 · Yingkun Xu, Guangzhen Wu, et al. · BioMed Research International · 52

Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma

2020 · Jianyi Li, Guangzhen Wu, et al. · BioMed Research International · 38

A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma

2020 · Yingkun Xu, Xiunan Li, et al. · PPAR Research · 27

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro

2020 · Yingkun Xu, Guangzhen Wu, et al. · BioMed Research International · 19

Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma

2020 · Guangzhen Wu, Yingkun Xu, et al. · International Journal of Medical Sciences · 14

Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types

2020 · Guangzhen Wu, Yingkun Xu, et al. · Journal of Cancer · 12

Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes.

2020 · Yingkun Xu, Guangzhen Wu, et al. · PubMed Central · 11

Comparison of the Fatty Acid Metabolism Pathway in Pan-Renal Cell Carcinoma: Evidence from Bioinformatics

2021 · Ping Wu, Yingkun Xu, et al. · Analytical Cellular Pathology · 3

Works count: 8

Citation count: 176

H-index: 7

I10-index: 7